Uppthera

Uppthera, founded in 2023 by Nicolas Gauthier and Quentin Vassileff, operates within the digital health sector with a focus on improving therapeutic adherence for patients with chronic illnesses. Gauthier, with his background as a pharmacist and experience at companies like Bristol Myers Squibb and Sanofi, coupled with Vassileff's expertise in business development and strategy, identified a critical gap in patient care. Their shared vision led to the creation of a platform designed to support patients in managing their treatments effectively.

The company's core offering is a digital therapeutic solution that gamifies the treatment process for individuals, particularly children, managing chronic conditions. By transforming treatment management into an engaging experience, Uppthera aims to enhance patient motivation and adherence. This solution also serves as a valuable tool for healthcare professionals and pharmaceutical companies by providing insights into treatment efficacy and patient behavior through the collection of real-world data. The platform facilitates better communication and follow-up between patients and their healthcare providers, aiming to improve overall health outcomes.

Uppthera's business model targets pharmaceutical laboratories, offering them a platform to support patients using their medications. This B2B approach generates revenue by providing pharmaceutical clients with a tool to increase the value of their treatments through improved patient adherence and data collection. The company has participated in several acceleration programs, including Wilco, Genopole, and HEC incubator at Station F, securing initial funding to support its development and pilot projects.

Keywords: digital therapeutics, patient adherence, chronic illness management, gamification in healthcare, pediatric health, real-world data, pharmaceutical support, health technology, patient engagement, medication management